Novo Holdings A/S 13D/13G Filings for

Novo Holdings A/S 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
9:00 pm
Purchase
2025-02-07 13G ArriVent BioPharma, Inc. Common Stock
AVBP
Novo Holdings A/S 1,750,000
5.200%
1,750,000increase
(New Position)
Filing